Currently out of the existing stock ratings of Vikram Purohit, 86 are a BUY (40.38%), 120 are a HOLD (56.34%), 7 are a SELL (3.29%).

Vikram Purohit

Work Performance Price Targets & Ratings Chart

Analyst Vikram Purohit, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 57.82% that have a potential upside of 37.08% achieved within 177 days.

Vikram Purohit’s has documented 453 price targets and ratings displayed on 29 stocks. The coverage is on Healthcare, Consumer Defensive sectors.

Most recent stock forecast was given on RXRX, Recursion Pharmaceuticals at 14-May-2026.

Wall Street Analyst Vikram Purohit

Analyst best performing recommendations are on TAL (TAL EDUCATION GROUP).
The best stock recommendation documented was for TAL (TAL EDUCATION GROUP) at 6/1/2021. The price target of $35 was fulfilled within 2 days with a profit of $5.51 (13.6%) receiving and performance score of 68.01.

Average potential price target upside

of $345.26 (19.66%) on ARGX (ARGENX NV ADR).
of $58.85 (57.78%) on TALS (TALARIS THERAPEUTICS).
of $32.67 (30.97%) on ASND (ASCENDIS PHARMA AS).

AXSM Axsome Therapeutics CERT Certara FHTX Foghorn Therapeutics HOOK Hookipa Pharma INCY yte KYMR Kymera Therapeutics RDUS Schnitzer Steel Industries SAGE Sage Therapeutic TALS Talaris Therapeutics TBPH Theravance Biopharma EVLO Evelo Biosciences EXAI Exscientia Ltd ADR TIL Instil Bio RGNX Regenxbio SDGR Schrodinger ARQT Arcutis Biotherapeutics ASND Ascendis Pharma AS AKLI Akili HALO Halozyme Therapeutics BMRN Biomarin Pharmaceutical CMPS Compass Pathways Plc GMAB Genmab AS RXRX Recursion Pharmaceuticals ABVX Abivax SA American Depositary Shares SLRN ACELYRIN, INC. Common Stock ABSI Absci Corp ARGX argenx NV ADR TAL TAL Education Group TSVT 2Seventy Bio

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Graig Suvannavejh (MIZUHO)